Works matching IS 00071048 AND DT 2013 AND VI 162 AND IP 2

Results: 19
    1

    A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 191, doi. 10.1111/bjh.12359
    By:
    • Ossenkoppele, Gert J.;
    • Lowenberg, Bob;
    • Zachee, Pierre;
    • Vey, Norbert;
    • Breems, Dimitri;
    • Loosdrecht, Arjan A.;
    • Davidson, Alan H.;
    • Wells, Graham;
    • Needham, Lindsey;
    • Bawden, Lindsay;
    • Toal, Martin;
    • Hooftman, Leon;
    • Debnam, Phillip M.
    Publication type:
    Article
    2
    3

    Variable age of onset and clinical severity in transferrin receptor 2 related haemochromatosis: novel observations.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 278, doi. 10.1111/bjh.12350
    By:
    • Bardou‐Jacquet, Edouard;
    • Cunat, Severine;
    • Beaumont‐Epinette, Marie‐Pascale;
    • Kannengiesser, Caroline;
    • Causse, Xavier;
    • Sauvion, Sylvie;
    • Pouliquen, Bruno;
    • Deugnier, Yves;
    • David, Veronique;
    • Loréal, Olivier;
    • Aguilar‐Martinez, Patricia;
    • Brissot, Pierre;
    • Jouanolle, Anne‐marie
    Publication type:
    Article
    4
    5

    rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 221, doi. 10.1111/bjh.12366
    By:
    • Sava, Georgina P.;
    • Speedy, Helen E.;
    • Bernardo, Maria Chiara;
    • Deaglio, Silvia;
    • Karabon, Lidia;
    • Frydecka, Irena;
    • Woszczyk, Dariusz;
    • Rossi, Davide;
    • Gaidano, Gianluca;
    • Mansouri, Larry;
    • Smedby, Karin E.;
    • Juliusson, Gunnar;
    • Rosenquist, Richard;
    • Catovsky, Daniel;
    • Houlston, Richard S.
    Publication type:
    Article
    6
    7
    8

    TRIM13 ( RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 210, doi. 10.1111/bjh.12365
    By:
    • Gatt, Moshe E.;
    • Takada, Kohichi;
    • Mani, Mala;
    • Lerner, Mikael;
    • Pick, Marjorie;
    • Hideshima, Teru;
    • Carrasco, Daniel E.;
    • Protopopov, Alexei;
    • Ivanova, Elena;
    • Sangfelt, Olle;
    • Grandér, Dan;
    • Barlogie, Bart;
    • Shaughnessy, John D.;
    • Anderson, Kenneth C.;
    • Carrasco, Daniel R.
    Publication type:
    Article
    9
    10
    11

    Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 202, doi. 10.1111/bjh.12361
    By:
    • Pönisch, Wolfram;
    • Heyn, Simone;
    • Beck, Juliane;
    • Wagner, Ina;
    • Mohren, Martin;
    • Hoffmann, Franz A.;
    • Lange, Thoralf;
    • Schmalfeld, Marion;
    • Zehrfeld, Thomas;
    • Schwarzer, Andreas;
    • Winkelmann, Cornelia;
    • Edelmann, Thomas;
    • Röhrborn, Ramona;
    • Hebenstreit, Karin;
    • Al‐Ali, Haifa K.;
    • Jäkel, Nadja;
    • Niederwieser, Dietger
    Publication type:
    Article
    12

    Micro RNAs in myeloid malignancies.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 162, doi. 10.1111/bjh.12364
    By:
    • Gordon, Jane E. A.;
    • Wong, Justin J.‐L.;
    • Rasko, John E. J.
    Publication type:
    Article
    13

    Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 229, doi. 10.1111/bjh.12375
    By:
    • Harrison, Claire N.;
    • Mesa, Ruben A.;
    • Kiladjian, Jean‐Jacques;
    • Al‐Ali, Haifa‐Kathrin;
    • Gisslinger, Heinz;
    • Knoops, Laurent;
    • Squier, Margaret;
    • Sirulnik, Andres;
    • Mendelson, Estella;
    • Zhou, Xiaolei;
    • Copley‐Merriman, Catherine;
    • Hunter, Deborah S.;
    • Levy, Richard S.;
    • Cervantes, Francisco;
    • Passamonti, Francesco;
    • Barbui, Tiziano;
    • Barosi, Giovanni;
    • Vannucchi, Alessandro M.
    Publication type:
    Article
    14

    High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R- NIMP GOELAMS study.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 240, doi. 10.1111/bjh.12379
    By:
    • Gyan, Emmanuel;
    • Damotte, Diane;
    • Courby, Stéphane;
    • Sénécal, Delphine;
    • Quittet, Philippe;
    • Schmidt‐Tanguy, Aline;
    • Banos, Anne;
    • Gouill, Steven;
    • Lamy, Thierry;
    • Fontan, Jean;
    • Maisonneuve, Hervé;
    • Alexis, Magda;
    • Dreyfus, Francois;
    • Tournilhac, Olivier;
    • Laribi, Kamel;
    • Solal‐Céligny, Philippe;
    • Arakelyan, Nina;
    • Cartron, Guillaume;
    • Gressin, Remy
    Publication type:
    Article
    15
    16
    17
    18
    19

    Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 250, doi. 10.1111/bjh.12370
    By:
    • Lacayo, Norman J.;
    • Alonzo, Todd A.;
    • Gayko, Urte;
    • Rosen, David B.;
    • Westfall, Matt;
    • Purvis, Norman;
    • Putta, Santosh;
    • Louie, Brent;
    • Hackett, James;
    • Cohen, Aileen Cleary;
    • Cesano, Alessandra;
    • Gerbing, Robert;
    • Ravindranath, Yaddanapudi;
    • Dahl, Gary V.;
    • Gamis, Alan;
    • Meshinchi, Soheil
    Publication type:
    Article